PAOLA-1: Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer Last updated on Mar 9, 2024 Previous GOG 209: Carboplatin and Paclitaxel for Advanced Endometrial Cancer Next SHAPE Trial: Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
